SeaStar Medical Holding (ICU) Payables (2020 - 2026)
SeaStar Medical Holding's (ICU) quarterly Payables came in at $1.0 million in Q1 2026, down 72.07% YoY from $3.8 million in Q1 2025, and down 28.72% on a QoQ basis from $1.5 million in Q4 2025.
SeaStar Medical Holding (ICU) Payables (2020 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has 7 years of Payables data on file, last reported at $1.0 million in Q1 2026.
- Quarterly Payables fell 72.07% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (down 72.07% YoY) and the FY2025 annual result came in at $1.5 million, down 59.31% from the prior year.
- Payables declined to $1.0 million in Q1 2026, from $1.5 million in the prior quarter.
- In the past five years, Payables ranged from a high of $10.3 million in Q2 2023 to a low of $1.0 million in Q1 2026.
- A 5-year average of $3.9 million and a median of $3.6 million in 2024 frame the typical range for Payables.
- Annual changes were most pronounced in 2022 — Payables jumped 3552.94% — and 2026, when it plunged 72.07%.
- Tracing ICU's Payables over 5 years: stood at $3.1 million in 2022, then jumped by 59.0% to $4.9 million in 2023, then slipped by 26.68% to $3.6 million in 2024, then sank by 59.31% to $1.5 million in 2025, then decreased by 28.72% to $1.0 million in 2026.
- The last three Payables figures came in at $1.0 million (Q1 2026), $1.5 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | SeaStar Medical Holding | 13.68 Mn | 6.68 Mn | 561,000.00 | 884,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 884,000.00 |
| Mar 31, 2026 | 1.05 Mn |
| Dec 31, 2025 | 1.47 Mn |
| Sep 30, 2025 | 2.02 Mn |
| Jun 30, 2025 | 3.16 Mn |
| Mar 31, 2025 | 3.76 Mn |
| Dec 31, 2024 | 3.62 Mn |
| Sep 30, 2024 | 3.69 Mn |
| Jun 30, 2024 | 6.72 Mn |
| Mar 31, 2024 | 4.24 Mn |
| Dec 31, 2023 | 4.94 Mn |
| Sep 30, 2023 | 5.04 Mn |
| Jun 30, 2023 | 10.26 Mn |
| Mar 31, 2023 | 3.52 Mn |
| Dec 31, 2022 | 3.11 Mn |
| Sep 30, 2022 | 1.87 Mn |
| Dec 31, 2021 | 85,000.00 |
| Dec 31, 2020 | 249,444.00 |